Fig. 1From: Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapyImmunohistochemical images showing typical BCL2 positivity (upper) and negativity (lower) (immunoperoxidase staining with hematoxylin counterstaining)Back to article page